Research on the Harmonious Development of China's Old-age Care Institutions

Authors

  • Jing Li College of Humanities and Social Sciences, Heilongjiang Bayi Agricultural University, Daqing 163319, China

DOI:

https://doi.org/10.53469/jtpms.2024.04(05).05

Keywords:

Old-age care institutions, imbalanced, harmonious development

Abstract

With the development of socialization, old-age care institutions have been paid attention to in the old-age security system. After the occurrence of the "Black Heart Retirement Home" incident, we have to consider the imbalances in the development of old-age care institutions. Analysis of the current imbalance and its causes, hoping to find a solution to the problem of imbalance, to effectively prevent the occurrence of similar incidents, and solve the worry of the elderly.

References

Wei Lv, Weitong Wang: Development imbalances, public services and government responsibilities, Social Sciences in China,Vol.29(2008)No.4,p.55.

Shixun Gui:Reasonably adjust the functional institutions of old-age care institutions, Journal of East China Normal University(Humanities and Social Sciences),Vol.49(2001)No.4,p.98.

Xinping Lv:The Demand of the Elderly in Nursing Homes and the Specialization of Nursing Agencies: A Case Study of a Nursing Home in Beijing,Population & Economics,Vol.25(2004) No.1,p.68.

Wen, H., Ken C. H., Gao, J. J. & Li, Y. (2022). The fundamental effects of ESG disclosure quality in boosting the growth of ESG investing. Journal of International Financial, Markets, Institutions and Money. 81, 101655, ISSN 1042-4431.

Lai, X. B. & Zhang, F. (2022). Can ESG certification help company get out of over-indebtedness? Evidence from China. Pacific-Basin Finance Journal, 76, 101878, ISSN 0927-538X.

Pan, et al. (2022). “ ESG disclosure in China: A critical challenge for enterprises. ” Journal of Corporate Governance, 15(3), 45-60.

Claessens, S. & Yurtoglu, B. (2013). Corporate governance in emerging markets: A survey, Emerging Markets Review. 15, 1-33, ISSN 1566-0141.

Shahab, Y., Gull, A. A., Rind, A. A., Sarang, A. A. A. & Ahsan, T. (2022). Do corporate governance mechanisms curb the anti-environmental behavior of firms worldwide? An illustration through waste management. Journal of Environmental Management, 310, 114707, ISSN 0301-4797.

Christopher, S. A., Jennifer L. B., Alan, D., Jagolinzer, David, F. & Larcker. (2015). Corporate governance, incentives, and tax avoidance. Journal of Accounting and Economics, 60(1), 1-17, ISSN 0165-4101.

Armstrong, C.S., Blouin, J.L., & Jagolinzer, A.D. (2015). Corporate governance, incentives, and tax avoidance. Journal of Accounting and Economics, 60(1), 1-17.

Amore, M. D. & Bennedsen, M. (2016). Corporate governance and green innovation. Journal of Environmental Economics and Management, 75, 54-72, ISSN 0095-0696.

Jiang, F., & Kim, Y. C. (2020). Horizontal agency conflict between controlling shareholders and minority shareholders in China: Evidence from equity concentration. International Journal of Economics, Commerce and Management, 8(1), 16-25.

Wang, J. X., Ma, M. D., Dong, T. Y., Zhang, Z. Y. (2023). Do ESG ratings promote corporate green innovation? A quasi-natural experiment based on SynTao Green Finance’s ESG ratings. International Review of Financial Analysis, 87, 102623, ISSN 1057-5219.

Zouaoui M, Nouyrigat G, Beer F. How does investor sentiment effect stock market crises? Evidence from panel data. Financial Review. 2011; 46 (4): 723-747.

Aifuwa H O , Saidu M , Aifuwa S A . Coronavirus Pandemic Outbreak and Firms Performance in Nigeria[J]. Human Resource Management Review, 2020, 9(4):15-25.

Donadelli M, Kizys R, Riedel M. Dangerous infective diseases: Bad news for Main Street, good news for Wall Street? Journal of Financial Markets. 2017; 35.

West NEJ, Cheong WF, Boone E, Moat NE. Impact of the COVID-19 pandemic: a perspective from industry. Eur Heart J Suppl. Dec 2020; 22 (Suppl Pt t): P56-P59.

Ural D. Title of subordinate document. In: Evaluating Pharma Amid COVID-19. https://www.contactpharma.com/contents/view_online-exclusives/2020-05-18/evaluating-pharma-amid- covid-19/. Accessed 18 May 2020.

Sun Y, Bao Q, Lu Z. Coronavirus (Covid-19) outbreak, investor sentiment, and medical portfolio: Evidence from China, Hong Kong, Korea, Japan, and U.S. Pacific-Basin Finance Journal. 2021; 65 (4): 101,463.

Wang Z, Zhang Z, Zhang Q, Gao J, Lin W. COVID-19 and financial market response in China: Micro evidence and possible mechanisms.PLoS One. 2021; 16 (9): e0256879.

Zheng F, Zhao Z, Sun Y, Khan YA. Financial performance of China's listed firms in presence of coronvirus: Evidence from corporate culture and corporate social responsibility.Curr Psychol.Aug 11 201: 1-22.

Ali M, Alam N, Rizvi S. Coronavirus (COVID-19)-An Epidemic or Pandemic for Financial Markets. Journal of Behavioral and Experimental Finance. 2020 27: 100341..

Da A, Sb B, Jmb C, et al. Economic Before and During the COVID-19 pandemic.Journal of Public Economic.2020; 191.

Downloads

Published

2024-05-31

How to Cite

Li, J. (2024). Research on the Harmonious Development of China’s Old-age Care Institutions. Journal of Theory and Practice of Management Science, 4(05), 34–40. https://doi.org/10.53469/jtpms.2024.04(05).05